$WNTR Recent Headlines

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$WNTR Recent Headlines






Worldwide Evaluating Media and Entertainment Opportunities
10:15 a.m. May 2, 2014
- Marketwire




Green Company Holdings Evaluating Land Acquisitions
10:15 a.m. April 29, 2014
- Marketwire




Worldwide to List Green Company Holdings
10:15 a.m. April 25, 2014
- Marketwire




I-Texts Commences Nationwide Mobile Advertising Campaign
10:15 a.m. April 24, 2014
- Marketwire




Worldwide Signs Letter of Intent With Hydro Pharms
10:15 a.m. April 21, 2014
- Marketwire




Worldwide Signs Agreement With New Green Fund Company
10:15 a.m. April 16, 2014
- Marketwire




Worldwide Completes Investment in TeleMedCare
10:16 a.m. April 11, 2014
- Marketwire




Worldwide Signs Letter of Intent for New Green Fund Company
10:15 a.m. April 8, 2014
- Marketwire




Worldwide Provides Shareholder Update on Solar Project
11:16 a.m. April 3, 2014
- Marketwire




SinglePoint(TM), Inc. Partnership With Worldwide Internet, Inc.
Allows for Introduction of SING's Mobile Donation Platform to 300+
Charities
9:10 a.m. April 1, 2014
- Marketwire




Worldwide Provides Shareholder Update on The Green Fund
11:15 a.m. March 31, 2014
- Marketwire




Worldwide Reports Record Results for Fiscal Year 2013
2:25 p.m. March 28, 2014
- Marketwire




Worldwide Portfolio Company Completes Acquisition of I-Texts
3:00 p.m. March 25, 2014
- Marketwire




Worldwide Announces Appointment of Director
1:40 p.m. March 19, 2014
- Marketwire




Worldwide Announces Partnership With SinglePoint
10:15 a.m. March 11, 2014
- Marketwire




SinglePoint(TM), Inc. Announces Partnership With Green Company
Holdings, Inc. for Leveraged Opportunities in Payment Systems for the
Medical Cannabis Industry
9:10 a.m. March 11, 2014
- Marketwire




Worldwide Completes Acquisition of Interest in E3
10:50 a.m. March 7, 2014
- Marketwire




Worldwide Forms The Green Fund
10:15 a.m. Feb. 28, 2014
- Marketwire




Worldwide CEO Interviewed on Radio Program
10:15 a.m. Feb. 26, 2014
- Marketwire




Worldwide Completes Transaction With Hemp Market Watch
10:15 a.m. Feb. 21, 2014
- Marketwire




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading